Maintaining results of successful induction treatment is an important goal in myeloma and the use of maintenance treatment to achieve this has been investigated for a number of years. Here, members of the International Myeloma Working Group review the relevant data and draw a consensus on maintenance treatment in myeloma.
In this article, members of the International Myeloma Working Group review the available data and provide new recommendations for the management of MGUS and smouldering myeloma patients.
In this paper, members of the International Myeloma Working Group summarise the data from prospective and retrospective studies of allogeneic stem cell transplantation in myeloma and provide recommendations for new safer approaches whilst preserving the graft versus myeloma effect.
This paper, produced by the International Myeloma Working Group, summarises the available evidence and provides recommendations for a prophylaxis strategy according to a risk assessment model, to reduce the risk of a venous thromboembolic event in myeloma patients.
This paper, written by an expert panel on behalf of the International Myeloma Working Group, outlines the state of knowledge of treatment-induced peripheral neuropathy in myeloma patients and the various management practices, providing recommendations for the optimal management of patients who develop peripheral neuropathy during treatment.
This article, written by the International Myeloma Working Group, reviews the evidence and provides a consensus on the diagnostic criteria, response criteria and treatment recommendations for primary plasma cell leukemia.
This article, written by an expert panel on behalf of the International Myeloma Working Group, discusses a variety of issues regarding stem cell collection and transplantation in myeloma and the role of plerixafor, providing a summary of the deliberations and conclusions.
This paper, written by an expert panel on behalf of the International Myeloma Working Group, provides consensus guidelines for the use of the serum free light chain assay in the diagnosis and management of clonal plasma cell disorders.
This paper, written by a joint working group established by the Haemato-oncology subgroup of the British Committee for Standards in Haematology and the British Society for Bone Marrow Transplantation, reviews the available literature and made recommendations for the supportive care and management of organ-specific complications of chronic graft-versus-host disease (cGvHD).
This guideline, produced by a joint working group established by the Haemato-Oncology subgroup of the British Committee for Standards in Haematology (BCSH) and the British Society for Bone Marrow Transplantation (BSBMT) reviews the available literature and makes recommendations for the diagnosis and management of chronic graft-versus-host disease (GvHD).